All News

The FDA is alerting health care professionals and patients of a voluntary recall of several, but not all, drug products containing the active ingredient valsartan.

The discovery may pave the way for the development of personalized medicine in order to target this newly discovered form of the disease.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

A new study provides insight into previously unknown details about the capsid that may have implications for the development of new drugs to treat the infection.

The CDC and FDA are currently investigating a multistate outbreak of Cyclospora infections (cyclosporiasis) linked to McDonald’s salads.

Officials with the US FDA are alerting health care professionals and patients of a voluntary recall of several, but not all, drug products containing the active ingredient valsartan.

Enzalutamide (Xtandi) is the first and only FDA-approved oral medication for both non-metastatic and metastatic castration-resistant prostate cancer.

Officials with the FDA have approved tecovirimat (TPOXX, SIGA), the first drug with an indication for the treatment of smallpox, to boost preparedness in the event of a bioterror attack

Study suggests that covering high-value medications benefits patients at no extra cost to insurers.

Although eradicated in 1980 due to vaccination efforts, there have been concerns of the virus being used as a potential weapon in bioterrorism.

Tecovirimat (TPOXX, SIGA) is the first drug with an indication for the treatment of smallpox.

Researchers aim to determine whether an annual brain volume loss rate of less than 0.4% is a valid marker to assess treatment response.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The discontinuation of opioid therapy may address the rising death toll caused by drug overdoses while maintaining or potentially improving chronic, non-cancer pain in patients, according to a recent study.

With this new indication, enzalutamide is the first and only FDA-approved oral medication for both non-metastatic and metastatic CRPC.

With Amazons purchase of PillPack, it leaves me wondering what other companies they may be considering in the pharmacy space.

Student pharmacists at 2 universities in vastly different communities will learn how the other half practices pharmacy during a new program that will send each group across the country.

Some companies are recalling all lots of non-expired products that contain the ingredient valsartan supplied by a third-party.

Pharmacists will provide first aid and over-the-counter treatments along the RAGBRAI route, which stretches more than 400 miles across Iowa.

Cognitive impairment is present in up to 70% of patients with multiple sclerosis, but can be difficult to completely evaluate in routine clinical practice.

Top news of the week from The American Journal of Pharmacy Benefits.

Top news of the week from Specialty Pharmacy Times.

SensorRx is utilizing patient-generated health data that links to the physician in order to improve outcomes for the patient population.

Significant progress has been made in gene therapy research and development over the years, with promise to treat and cure some of the most complex diseases.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The FDA has issued disease-specific draft guidances for the development of gene therapies for certain conditions.

Mobile health interventions have the potential to help people living with HIV improve engagement in care, promote medication adherence, and in turn, improve patient outcomes.